February 5th, 2021 · Common Contracts · 1000 similar InMed Pharmaceuticals Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 5, 2021, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of February 5, 2021, between InMed Pharmaceuticals Inc., a company incorporated under the laws of the Province of British Columbia (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
February 19th, 2016 · Common Contracts · 1000 similar Advisors Disciplined Trust 1591 – DORSEY Dorsey & Whitney LLP February 19, 2016 The Bank of New York Mellon as Trustee of Advisors Disciplined Trust 1591 BNY Atlantic Terminal14 2 Hanson Place, 12th Floor Brooklyn, NY 11217 Ladies and Gentlemen: We are acting as your counsel in...
April 25th, 2022 · Common Contracts · 1000 similar Tri-State Generation & Transmission Association, Inc. – AMENDED AND RESTATED CREDIT AGREEMENT Dated as of April 25, 2022 among TRI- STATE GENERATION AND TRANSMISSION ASSOCIATION, INC., as the Borrower, The LENDERS Party Hereto, and NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORPORATION, as Administrative...
March 21st, 2018 · Common Contracts · 990 similar Deluxe Corp – CREDIT AGREEMENT dated as of March 21, 2018 among CREDIT AGREEMENT (this “Agreement”) dated as of March 21, 2018 among DELUXE CORPORATION, as Borrower, the LENDERS from time to time party hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent and FIFTH THIRD BANK, SUNTRUST BANK and U.S. BANK NATIONAL ASSOCIATION as Co-Syndication Agents and BMO HARRIS BANK N.A., PNC BANK, NATIONAL ASSOCIATION, THE BANK OF TOKYO MITSUBISHI UFJ, LTD. and BANK OF AMERICA, N.A., as Co-Documentation Agents.
CREDIT AGREEMENT (this “Agreement”) dated as of March 21, 2018 among DELUXE CORPORATION, as Borrower, the LENDERS from time to time party hereto, JPMORGAN CHASE BANK, N.A., as Administrative Agent and FIFTH THIRD BANK, SUNTRUST BANK and U.S. BANK NATIONAL ASSOCIATION as Co-Syndication Agents and BMO HARRIS BANK N.A., PNC BANK, NATIONAL ASSOCIATION, THE BANK OF TOKYO MITSUBISHI UFJ, LTD. and BANK OF AMERICA, N.A., as Co-Documentation Agents.
October 8th, 2021 · Common Contracts · 791 similar Harbor Custom Development, Inc. – UNDERWRITING AGREEMENT between HARBOR CUSTOM DEVELOPMENT, INC. And THINKEQUITY LLC as Representative of the Several Underwriters The undersigned, Harbor Custom Development, Inc., a corporation formed under the laws of the State of Washington (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Harbor Custom Development, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
The undersigned, Harbor Custom Development, Inc., a corporation formed under the laws of the State of Washington (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Harbor Custom Development, Inc., the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
July 16th, 2020 · Common Contracts · 627 similar Inmune Bio, Inc. – INMUNE BIO INC. UNDERWRITING AGREEMENT
April 6th, 2018 · Common Contracts · 609 similar Advisors Disciplined Trust 1860 – April 6, 2018
March 16th, 2007 · Common Contracts · 532 similar Ats Medical Inc – ARTICLE I. DEFINITIONS
December 13th, 2011 · Common Contracts · 467 similar Synovis Life Technologies Inc – AGREEMENT AND PLAN OF MERGER AMONG BAXTER INTERNATIONAL INC., TWINS MERGER SUB, INC. AND SYNOVIS LIFE TECHNOGIES, INC. Dated as of December 12, 2011 THIS AGREEMENT AND PLAN OF MERGER, dated as of December 12, 2011 (this “Agreement”), is made by and among Baxter International Inc., a Delaware corporation (“Parent”), Twins Merger Sub, Inc., a Minnesota corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and Synovis Life Technologies, Inc., a Minnesota corporation (the “Company”).
THIS AGREEMENT AND PLAN OF MERGER, dated as of December 12, 2011 (this “Agreement”), is made by and among Baxter International Inc., a Delaware corporation (“Parent”), Twins Merger Sub, Inc., a Minnesota corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and Synovis Life Technologies, Inc., a Minnesota corporation (the “Company”).
January 17th, 2001 · Common Contracts · 449 similar Cytomedix Inc – REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT"), dated as of December 26, 2000, by and among CYTOMEDIX, INC., a Delaware corporation, with its headquarters located at Three Parkway North, Deerfield, Illinois 60015 (the...
August 4th, 2016 · Common Contracts · 374 similar Cesca Therapeutics Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of August 3, 2016, between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of August 3, 2016, between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
March 30th, 2022 · Common Contracts · 374 similar Vyant Bio, Inc. – REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 28, 2022, by and between VYANT BIO, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 28, 2022, by and between VYANT BIO, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).
January 12th, 2022 · Common Contracts · 370 similar Avinger Inc – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of January 12, 2022, between Avinger, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
This Securities Purchase Agreement (this “Agreement”) is dated as of January 12, 2022, between Avinger, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
May 19th, 2022 · Common Contracts · 349 similar Invesco Unit Trusts Series 2215 – Dorsey & Whitney LLP New York, New York 10019-6119 We are acting as your counsel in connection with the execution and delivery by you of a certain trust agreement, dated as of today (the “Indenture”), among Invesco Capital Markets, Inc., as depositor (the “Depositor”), Invesco Investment Advisers LLC, as supervisor (the “Supervisor”), and you, as Trustee, establishing Invesco Unit Trusts, Series 2215, and the registration by you, as Trustee, on the registration books of the Trust, of ownership of all of the units of fractional undivided interests in and ownership of the unit investment trust series contained in the Trust (“Units”), as set forth in the prospectus, dated today, for filing as an amendment to the registration statement heretofore filed with the Securities and Exchange Commission under the Securities Act of 1933, as amended (respectively the “Prospectus” and the “Registration Statement”). The Trust consists of the securities set forth in the Prospectus including delivery statements relating to contracts for the purchase of
We are acting as your counsel in connection with the execution and delivery by you of a certain trust agreement, dated as of today (the “Indenture”), among Invesco Capital Markets, Inc., as depositor (the “Depositor”), Invesco Investment Advisers LLC, as supervisor (the “Supervisor”), and you, as Trustee, establishing Invesco Unit Trusts, Series 2215, and the registration by you, as Trustee, on the registration books of the Trust, of ownership of all of the units of fractional undivided interests in and ownership of the unit investment trust series contained in the Trust (“Units”), as set forth in the prospectus, dated today, for filing as an amendment to the registration statement heretofore filed with the Securities and Exchange Commission under the Securities Act of 1933, as amended (respectively the “Prospectus” and the “Registration Statement”). The Trust consists of the securities set forth in the Prospectus including delivery statements relating to contracts for the purchase of
February 12th, 2021 · Common Contracts · 341 similar Conversion Labs, Inc. – SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 11, 2021, is by and among Conversion Labs, Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of February 11, 2021, is by and among Conversion Labs, Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
January 15th, 2013 · Common Contracts · 334 similar Kodiak Oil & Gas Corp – Kodiak Oil & Gas Corp. REGISTRATION RIGHTS AGREEMENT Reference is made to the purchase agreement dated as of January 10, 2013 (the “Purchase Agreement”) among Kodiak Oil & Gas Corp., a Yukon Territory corporation (the “Issuer”), Kodiak Oil & Gas (USA) Inc. (the “Subsidiary Guarantor” and together with the Issuer, the “Company”), and Wells Fargo Securities, LLC, RBC Capital Markets, LLC and Credit Suisse Securities (USA) LLC, as representatives (the “Representatives”) of the several purchasers named in Schedule A thereto (collectively, the “Purchasers”). The Issuer proposes to issue and sell to the Purchasers, upon the terms set forth in the Purchase Agreement, $350,000,000 aggregate principal amount of its 5.500% Senior Notes due 2021 (the “Initial Securities”) to be unconditionally guaranteed (the “Subsidiary Guarantee”) by the Subsidiary Guarantor. The Initial Securities will be issued pursuant to an Indenture, dated as of January 15, 2013 (the “Indenture”) among the Issuer, the Subsidiary Guarantor, U.S. Bank National Association, as
Reference is made to the purchase agreement dated as of January 10, 2013 (the “Purchase Agreement”) among Kodiak Oil & Gas Corp., a Yukon Territory corporation (the “Issuer”), Kodiak Oil & Gas (USA) Inc. (the “Subsidiary Guarantor” and together with the Issuer, the “Company”), and Wells Fargo Securities, LLC, RBC Capital Markets, LLC and Credit Suisse Securities (USA) LLC, as representatives (the “Representatives”) of the several purchasers named in Schedule A thereto (collectively, the “Purchasers”). The Issuer proposes to issue and sell to the Purchasers, upon the terms set forth in the Purchase Agreement, $350,000,000 aggregate principal amount of its 5.500% Senior Notes due 2021 (the “Initial Securities”) to be unconditionally guaranteed (the “Subsidiary Guarantee”) by the Subsidiary Guarantor. The Initial Securities will be issued pursuant to an Indenture, dated as of January 15, 2013 (the “Indenture”) among the Issuer, the Subsidiary Guarantor, U.S. Bank National Association, as
June 8th, 2021 · Common Contracts · 317 similar LifeMD, Inc. – LIFEMD, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
December 20th, 2004 · Common Contracts · 304 similar Diametrics Medical Inc – Contract THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO DIAMETRICS MEDICAL, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.
THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SAID ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO DIAMETRICS MEDICAL, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.
February 11th, 2022 · Common Contracts · 288 similar SmartTrust 554 – February 11, 2022 We are acting as counsel to The Bank of New York Mellon (“BNYM”) in connection with the execution and delivery by BNYM of a certain Standard Terms and Conditions of Trust dated July 21, 2015, and related Trust Agreement dated as of today’s date (collectively, the “Trust Agreement”) among Hennion & Walsh, Inc., as Depositor (the “Depositor”), Hennion & Walsh Asset Management, Inc., as Portfolio Supervisor (the “Portfolio Supervisor”), and BNYM, as Trustee establishing the Trust, and the execution by BNYM, as Trustee under the Trust Agreement, of a receipt for units evidencing ownership of all of the units of fractional undivided interest (such receipt for units and such aggregate units being herein respectively called “Receipt for Units” and “Units”) in the Trust, as set forth in the prospectus, (the “Prospectus”) included in the registration statement on Form S-6, as amended to the date hereof (the “Registration Statement”), relating to the Trust. The Trust consists of equity and/or de
We are acting as counsel to The Bank of New York Mellon (“BNYM”) in connection with the execution and delivery by BNYM of a certain Standard Terms and Conditions of Trust dated July 21, 2015, and related Trust Agreement dated as of today’s date (collectively, the “Trust Agreement”) among Hennion & Walsh, Inc., as Depositor (the “Depositor”), Hennion & Walsh Asset Management, Inc., as Portfolio Supervisor (the “Portfolio Supervisor”), and BNYM, as Trustee establishing the Trust, and the execution by BNYM, as Trustee under the Trust Agreement, of a receipt for units evidencing ownership of all of the units of fractional undivided interest (such receipt for units and such aggregate units being herein respectively called “Receipt for Units” and “Units”) in the Trust, as set forth in the prospectus, (the “Prospectus”) included in the registration statement on Form S-6, as amended to the date hereof (the “Registration Statement”), relating to the Trust. The Trust consists of equity and/or de
May 24th, 2007 · Common Contracts · 264 similar Syntax-Brillian Corp – SYNTAX-BRILLIAN CORPORATION (a Delaware corporation) 25,608,695 Shares of Common Stock (Par Value $.001 Per Share) PURCHASE AGREEMENT MERRILL LYNCH & CO. Merrill Lynch, Pierce, Fenner & Smith Incorporated as Representative of the several Underwriters 4 World Financial Center New York, New York 10080
MERRILL LYNCH & CO. Merrill Lynch, Pierce, Fenner & Smith Incorporated as Representative of the several Underwriters 4 World Financial Center New York, New York 10080
December 20th, 2004 · Common Contracts · 254 similar Diametrics Medical Inc – SUBSCRIPTION AGREEMENT THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of December 14, 2004, by and among Diametrics Medical, Inc., a Minnesota corporation (the “Company”), and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”).
THIS SUBSCRIPTION AGREEMENT (this “Agreement”), dated as of December 14, 2004, by and among Diametrics Medical, Inc., a Minnesota corporation (the “Company”), and the subscribers identified on the signature page hereto (each a “Subscriber” and collectively “Subscribers”).
June 7th, 2021 · Common Contracts · 253 similar Aytu Biopharma, Inc – Aytu BioPharma, Inc. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement Aytu BioPharma, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
Aytu BioPharma, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
December 18th, 2006 · Common Contracts · 245 similar St Jude Medical Inc – MULTI-YEAR CREDIT AGREEMENT Dated as of December 13, 2006 among ST. JUDE MEDICAL, INC., as the Borrower, BANK OF AMERICA, N.A., as Administrative Agent, L/C Issuer and Lender, THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., CHICAGO BRANCH, JPMORGAN CHASE... This MULTI-YEAR $1,000,000,000 CREDIT AGREEMENT (the “Agreement”) is entered into as of December 13, 2006, among ST. JUDE MEDICAL, INC., a Minnesota corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent, LC Issuer and Lender.
This MULTI-YEAR $1,000,000,000 CREDIT AGREEMENT (the “Agreement”) is entered into as of December 13, 2006, among ST. JUDE MEDICAL, INC., a Minnesota corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent, LC Issuer and Lender.
February 12th, 2021 · Common Contracts · 227 similar Conversion Labs, Inc. – REGISTRATION RIGHTS AGREEMENT This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 11, 2021, is by and among Conversion Labs, Inc., a Delaware corporation (the “Company”), and each of the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 11, 2021, is by and among Conversion Labs, Inc., a Delaware corporation (the “Company”), and each of the undersigned buyers (each, a “Buyer,” and collectively, the “Buyers”).
December 18th, 2007 · Common Contracts · 222 similar Reclamation Consulting & Applications Inc – EXHIBIT 4.4 REGISTRATION RIGHTS AGREEMENT ----------------------------- This Registration Rights Agreement (this "AGREEMENT") is made and entered into as of December 12, 2007, by and among Reclamation Consulting and Applications, Inc., a Colorado...
January 4th, 2022 · Common Contracts · 215 similar Austin Gold Corp. – AUSTIN GOLD CORP. UNDERWRITING AGREEMENT [ ] Common Shares Austin Gold Corp., a British Columbia corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) [ ] authorized but unissued shares (the “Firm Shares”) of common shares of the Company, no par value (the “Common Shares”). In addition, the Company also proposes to sell to the Underwriter, upon the terms and conditions set forth in Section 4 hereof, up to an additional [ ] authorized but unissued Common Shares (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares”. The Shares, the Underwriter Warrants (as defined below) and the Underwriter Warrant Shares (as defined below) are collectively referred to as the “Securities.”
Austin Gold Corp., a British Columbia corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”) [ ] authorized but unissued shares (the “Firm Shares”) of common shares of the Company, no par value (the “Common Shares”). In addition, the Company also proposes to sell to the Underwriter, upon the terms and conditions set forth in Section 4 hereof, up to an additional [ ] authorized but unissued Common Shares (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares”. The Shares, the Underwriter Warrants (as defined below) and the Underwriter Warrant Shares (as defined below) are collectively referred to as the “Securities.”
June 12th, 2012 · Common Contracts · 198 similar Integramed America Inc – AGREEMENT AND PLAN OF MERGER by and among SCP-325 HOLDING CORP., SCP-325 MERGER SUB, INC. and INTEGRAMED AMERICA, INC. Dated as of June 10, 2012 This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is entered into as of June 10, 2012 by and among SCP-325 Holding Corp., a Delaware corporation (“Parent”), SCP-325 Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and IntegraMed America, Inc., a Delaware corporation (the “Company”).
This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is entered into as of June 10, 2012 by and among SCP-325 Holding Corp., a Delaware corporation (“Parent”), SCP-325 Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and IntegraMed America, Inc., a Delaware corporation (the “Company”).
April 6th, 2015 · Common Contracts · 195 similar Aptose Biosciences Inc. – APTOSE BIOSCIENCES INC. US $20,000,000 SALES AGREEMENT Aptose Biosciences Inc., a corporation organized under the laws of Canada (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
Aptose Biosciences Inc., a corporation organized under the laws of Canada (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
May 15th, 2018 · Common Contracts · 193 similar AMEDICA Corp – UNDERWRITING AGREEMENT The undersigned, Amedica Corporation, a Delaware corporation (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Amedica Corporation, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for whom Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) for the purchase and sale of an aggregate of 15,000 Closing Units consisting of one share of the Company’s Preferred Stock and 758 Warrants to purchase one share of the Company’s Com
The undersigned, Amedica Corporation, a Delaware corporation (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Amedica Corporation, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for whom Maxim Group LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) for the purchase and sale of an aggregate of 15,000 Closing Units consisting of one share of the Company’s Preferred Stock and 758 Warrants to purchase one share of the Company’s Com
January 11th, 2002 · Common Contracts · 191 similar Carramerica Realty Corp – AND
December 4th, 2009 · Common Contracts · 184 similar Otter Tail Corp – OTTER TAIL CORPORATION BANC OF AMERICA SECURITIES LLC J.P. MORGAN SECURITIES INC. As Representatives of the several Underwriters c/o BANC OF AMERICA SECURITIES LLC One Bryant Park New York, NY 10036
BANC OF AMERICA SECURITIES LLC J.P. MORGAN SECURITIES INC. As Representatives of the several Underwriters c/o BANC OF AMERICA SECURITIES LLC One Bryant Park New York, NY 10036
March 7th, 2005 · Common Contracts · 171 similar Unitedhealth Group Inc – UnitedHealth Group Incorporated Debt Securities Underwriting Agreement From time to time UnitedHealth Group Incorporated, a Minnesota corporation (the “Company”), proposes to enter into one or more Pricing Agreements (each a “Pricing Agreement”) in the form of Annex I hereto, with such additions and deletions as the parties thereto may determine, and, subject to the terms and conditions stated herein and therein, to issue and sell to the firms named in Schedule I to the applicable Pricing Agreement (such firms constituting the “Underwriters” with respect to such Pricing Agreement and the securities specified therein) certain of its debt securities (the “Securities”) specified in Schedule II to such Pricing Agreement (with respect to such Pricing Agreement, the “Designated Securities”).
From time to time UnitedHealth Group Incorporated, a Minnesota corporation (the “Company”), proposes to enter into one or more Pricing Agreements (each a “Pricing Agreement”) in the form of Annex I hereto, with such additions and deletions as the parties thereto may determine, and, subject to the terms and conditions stated herein and therein, to issue and sell to the firms named in Schedule I to the applicable Pricing Agreement (such firms constituting the “Underwriters” with respect to such Pricing Agreement and the securities specified therein) certain of its debt securities (the “Securities”) specified in Schedule II to such Pricing Agreement (with respect to such Pricing Agreement, the “Designated Securities”).
September 29th, 2010 · Common Contracts · 161 similar ProUroCare Medical Inc. – SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of September 28, 2010, between ProUroCare Medical Inc., a Nevada corporation (the “Company”), and the purchaser identified on the signature page hereto (the “Purchaser”).
This Securities Purchase Agreement (this “Agreement”) is dated as of September 28, 2010, between ProUroCare Medical Inc., a Nevada corporation (the “Company”), and the purchaser identified on the signature page hereto (the “Purchaser”).
January 10th, 2018 · Common Contracts · 160 similar PogoTec, Inc. – SUBSCRIPTION AGREEMENT THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME.
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME.
March 15th, 2011 · Common Contracts · 158 similar Deluxe Corp – DELUXE CORPORATION, THE GUARANTORS PARTY HERETO and U.S. BANK NATIONAL ASSOCIATION As Trustee 7.00% Senior Notes Due 2019 INDENTURE Dated as of March 15, 2011 INDENTURE dated as of March 15, 2011 among Deluxe Corporation, a Minnesota corporation (the “Company”), the Subsidiary Guarantors party hereto and U.S. Bank National Association, a national banking association, as trustee (the “Trustee”).
INDENTURE dated as of March 15, 2011 among Deluxe Corporation, a Minnesota corporation (the “Company”), the Subsidiary Guarantors party hereto and U.S. Bank National Association, a national banking association, as trustee (the “Trustee”).